Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

D-0801-2021

September 03, 2021

Class III

Product summary

Firm
Meitheal Pharmaceuticals Inc
Event
Event 88619
Status
Terminated
Classification
Class III
Quantity
1,160 ten-pack cartons
Official record key
drug-enforcement:D-0801-2021

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023

Distribution pattern: Nationwide within the USA and India

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications